EG BioMed is excited to participate in BIO Asia–Taiwan 2025, one of Asia’s most influential biotech events, taking place from July 24 to 27 at the Taipei Nangang Exhibition Center, Hall 1 (4th Floor).
BIO Asia–Taiwan Exhibition 2025
- Date: July 24 (Thu) – 27 (Sun), 2025 | 10:00 AM – 6:00 PM (until 5:00 PM on July 27)
- Venue: 4F, Taipei Nangang Exhibition Center, Hall 1
- EG BioMed Booth Locations:
- Country Pavilion – M710 (U.S.A. Pavilion)
- Research & Industry, Incubation – N416 (Taipei Medical University)
Booth Map – EG BioMed @ BIO Asia–Taiwan 2025
About EG BioMed
EG BioMed is dedicated to developing multi-cancer blood tests centered on DNA methylation technology, combined with highly specific probe design and an automated qPCR workflow.
Our platform offers non-invasive, highly sensitive, and longitudinally trackable solutions for early cancer detection. We have launched our pancreatic cancer blood test and completed biomarker development for breast, colorectal, and lung cancers. Our core technologies have been granted invention patents in the U.S. and 27 other countries, demonstrating our strong global footprint. To accelerate clinical adoption, we established a CLIA-certified laboratory in Washington State, USA (CLIA Number: 50D2316600), and are actively pursuing CAP accreditation. Our Taiwan headquarters and laboratory are certified under ISO 13485, ISO 15189, and LDTs (Laboratory Developed Tests) to ensure compliance with quality and regulatory standards.
To schedule a meeting or learn more about our solutions, feel free to [Contact Us].